Cancer medicines - PowerPoint PPT Presentation


High Potent Medicines Conference - EU Edition-22nd - 24th May 2024

We are delighted to announce our 9th Annual MarketsandMarkets High Potent Medicines Conference, scheduled on 22nd - 24th May 2024, in Milan, Italy. This conference will evidence the presence of some great minds in the Medical and Pharmaceutical industry bringing you the solutions to the challenges f

0 views • 5 slides


Best Breast Cancer Hospital in Tamilnadu

One of the top hospitals for breast cancer treatment in Tamil Nadu is the Hospitals in Chennai. With a dedicated breast cancer clinic, it offers comprehensive care including advanced diagnostics, surgery, chemotherapy, and radiation therapy. The hospital boasts a team of experienced oncologists, sur

3 views • 4 slides



High Potent Medicines Conference -Right CDMO selection and partnership

Welcome to the MarketsandMarkets 9th High Potent Medicines Conference\u2013 the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). \n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/high-potent-medicines-conference-eu-edition\/

3 views • 6 slides


What you need to know about the HPV Vaccine

Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides


Buffett Cancer Center Training Navigator Program Overview

The Fred & Pamela Buffett Cancer Center offers a Training Navigator Program aimed at meeting Nebraska's cancer research education needs, addressing disparities, and guiding scholars in the pathway of cancer-related research training. The program focuses on facilitating career development, networking

0 views • 30 slides


Cancer Research Investment in Canada - Highlights November 2023

The Canadian Cancer Research Alliance (CCRA) is a collaboration of organizations funding cancer research in Canada to advance prevention, diagnosis, and treatment. Established in 2005, CCRA has grown to over 35 members and published strategic plans to enhance cancer research outcomes. The Alliance s

1 views • 40 slides


Pioneering new approaches in cancer care through nursing innovation

Pioneering cancer nurses in Europe are driving advancements in cancer care through innovative approaches, evidence-based knowledge, and personalized patient-centered care. They play a vital role in cancer prevention, healthcare policy enhancement, and education improvement. By putting patients and f

0 views • 12 slides


High Potent Medicines Conference - EU Edition | Milan, Italy

Welcome to the MarketsandMarkets 9th High Potent Medicines Conference\u2013 the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). This transformative event converges industry leaders and regulatory professionals on a singular platfor

0 views • 6 slides


Second Opinion On Cancer Treatment-Second Chance In Life- Dr. Manoj Dongare

Did you know that seeking a second opinion from an experienced cancer specialist in Pune could be the key to unlocking more effective cancer treatment options? When you are diagnosed with cancer and researching about the treatment options then you must take a second opinion for your treatment for be

1 views • 3 slides


Europe Cancer Diagnostics Market: Emerging Trends in Liquid Biopsy and Next-Gene

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides


Dostarlimab 7.5 mg /5 ml: Transforming Cancer Care Landscape in India

Cancer care in India is undergoing a paradigm shift with the introduction of a new immunotherapy treatment: Dostarlimab. This potent formulation (7.5 mg\/5 ml) promises to change the treatment paradigm for oncologists as well as patients fighting cancer. Dostarlimab 7.5 mg\/5 ml is a revolutionary i

5 views • 7 slides


Canadian Cancer Statistics 2023 Overview

The Canadian Cancer Statistics 2023 report provides a comprehensive analysis of cancer data, including trends, statistics, and insights for the year. The report covers various aspects of cancer, such as incidence rates, survival rates, types of cancers diagnosed, and advancements in cancer treatment

0 views • 31 slides


What is OxyContin

OxyContin, also available as Oxycodone, is an opioid medication. You can use it alone or with other medicines. One can buy OxyContin online without any delay or hassle. Strong prescription medicine use is when opioid treatment is needed to manage severe pain enough to require daily around-the-clock,

0 views • 4 slides


Latest Research Updates on Brain and CNS Cancer Studies

SWAG Network Brain & CNS Cancer Clinical Advisory Group provides research updates on national brain cancer recruitment, national vs. regional recruitment, and ongoing brain cancer studies in the SWAG region. Additionally, insights from the Cancer Patient Experience Survey 2021 shed light on patient

0 views • 10 slides


Ontario Breast Cancer Screening Program Overview

The Ontario Breast Screening Program (OBSP) is a quality-assured, population-based breast cancer screening initiative administered by Cancer Care Ontario. It aims to reduce breast cancer mortality through early detection by providing biennial screenings for average-risk women aged 50-74 and annual s

3 views • 21 slides


Cancer Therapy Evaluation Program (CTEP) Overview

The Cancer Therapy Evaluation Program (CTEP) aims to enhance cancer patients' lives by advancing cancer treatment through research and clinical trials. The Program includes a Protocol and Information Office (PIO) to streamline trial development processes. It funds national cancer research and focuse

0 views • 27 slides


Understanding Therapeutic Strategies Targeting Apoptosis in Cancer

Apoptosis, a form of programmed cell death, is crucial for cellular homeostasis. In cancer, inhibition of apoptosis processes allows cancer cells to survive and proliferate abnormally. Developing targeted treatments for apoptosis pathways is essential for improved outcomes in cancer therapy. Cell de

2 views • 22 slides


Understanding Generic Medicines: European Patients Academy

Generic medicines are equivalent to brand-name drugs in composition and effectiveness, but they are more affordable as their research costs have been covered. Learn about generic medicines, their quality standards, and benefits.

0 views • 8 slides


Transforming Lung Cancer Care in South West: Cancer Alliance Priorities

Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag

0 views • 23 slides


Empowering Cancer Prevention Through Nurse-Led Initiatives

Cancer nurses play a crucial role in raising awareness about effective cancer prevention methods, supporting the European Code Against Cancer, providing advice for risk reduction, promoting health literacy, and encouraging early diagnosis through screening programs. Their expertise and leadership ar

0 views • 30 slides


Understanding the Cancer Genome Atlas (TCGA) Project

The Cancer Genome Atlas (TCGA) project, initiated in 2005, aims to identify genetic mutations in cancer through genome sequencing. Supervised by the Center for Cancer Genomics, TCGA has expanded over the years, publishing numerous research articles and involving various tumor types. The project has

0 views • 7 slides


Expectations for Nursing Associates in Medicines Management

Medicines management is a crucial aspect of nursing practice to ensure patient safety and optimal treatment outcomes. This presentation highlights the expectations for nursing associates in administering medicines, emphasizing the need for adequate supervision, adherence to guidelines, and integrati

0 views • 17 slides


Cancer Survival Rates in Europe: Trends and Disparities

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides


Rapid Investigation Service Overview

The Wessex RIS is a new cancer referral pathway aimed at patients with concerning non-specific symptoms. Working in partnership with acute trusts in Wessex, the service provides timely investigations to exclude cancer in such patients. Established as part of the National Rapid Diagnostic Centre proj

0 views • 15 slides


Understanding Cancer Health Disparities and Initiatives

Exploring the concept of cancer health disparities, this content touches on the National Cancer Act of 1971, the impact of social determinants of health, and various initiatives such as the National Minority Cancer Awareness Week. It highlights efforts to reduce disparities through research, advocac

5 views • 8 slides


Understanding the Molecular Biology of Cancer: Insights into Cell Transformation and Tumorigenesis

Normal cells undergo defined lifespan processes, but disruptions in cell differentiation and apoptosis can lead to cancer development. Unchecked cell growth caused by genetic mutations results in tumors that can metastasize. Cancer is a multistep disease involving genetic changes, and major transfor

4 views • 26 slides


Understanding Cancer: Causes, Symptoms, and Prevention

Cancer is a disease characterized by the uncontrollable growth and spread of abnormal cells in the body. These cells form tumors that can be either cancerous (malignant) or non-cancerous (benign). Cancer can develop in various parts of the body and is often caused by genetic changes that affect cell

2 views • 21 slides


Cancer Patient Experience Survey Results 2019 - Somerset, Wiltshire, Avon, and Gloucestershire

Results of the National Cancer Patient Experience Survey 2019 for Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliance were presented. The survey captured experiences of adults diagnosed with cancer who had received care from primary diagnosis to follow-up support. The report highlighted b

0 views • 16 slides


Breast Cancer Survival Disparities by Molecular Subtypes in the US

Breast cancer molecular subtypes play a crucial role in determining survival outcomes. This study by Nadia Howlader, PhD, from the National Cancer Institute, presented the first nationally representative estimates of breast cancer survival by four main molecular subtypes. The research aimed to under

1 views • 23 slides


Understanding Endometrial Cancer: Risk Factors, Diagnosis, and Management

Endometrial cancer, the most common gynecological malignancy in women, presents with abnormal uterine bleeding and affects women mainly during menopause. Risk factors include hormonal stimulation and estrogen levels. Differentiating between types of endometrial cancer can impact treatment decisions.

3 views • 31 slides


Understanding Data Submission in Cancer Registry Systems

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

0 views • 11 slides


Advances in Anticoagulation Therapy for Cancer-Related VTE and Stroke

Recent studies have shown advancements in anticoagulation therapy for cancer patients with venous thromboembolism (VTE) and stroke prevention. Direct oral anticoagulants (DOACs) are now considered beneficial for treating VTE in cancer, offering advantages in administration and efficacy. Different an

3 views • 9 slides


Liverpool Health Partners Cancer Programme: Enhancing Cancer Outcomes Through Collaborative Research

Liverpool Health Partners (LHP) Cancer Programme led by Prof. Andrew Pettitt and Dr. Matina Tsalavouta aims to reduce cancer incidence and mortality, improve patient quality of life, and align with the One Liverpool strategy. The comprehensive strategy focuses on inclusive consultation, engagement,

2 views • 13 slides


Overview of NHS New Medicines Service Technical Toolkit

The NHS New Medicines Service Technical Toolkit provides a high-level overview of the technical components required to deliver the New Medicines Service. It includes details on referral and reporting pathways, essential and desirable technical components, and future requirements. The service is adva

0 views • 18 slides


Accessing Medicines for Palliative Care Patients Near End of Life in West Sussex

Pharmacies in West Sussex have committed to stocking a range of medicines used in palliative care for individuals near the end of life. The listed pharmacies can be helpful in emergency situations when the usual pharmacy is unable to provide the needed medicines. It is advised to confirm the availab

0 views • 9 slides


Humber, Coast and Vale Cancer Alliance - Cancer Champions Programme Overview

The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in

0 views • 10 slides


ASEAN Guidelines on GMP for Traditional Medicines - Philosophy of Inspection

The ASEAN Guidelines on GMP for Traditional Medicines highlight the Philosophy of Inspection for ensuring quality and safety in traditional medicines and health supplements. The document covers legal terms, audit trail requirements, electronic signature control, and familiar auditor requirements. It

0 views • 88 slides


Understanding Cancer Registries and Their Significance

Cancer registries serve as vital information systems for collecting, storing, and analyzing cancer data to aid in research, prevention, treatment, and public health efforts. They help track cancer incidence, assist in identifying trends, and provide essential information to healthcare professionals

0 views • 18 slides


Patient Mobility and Cancer: Role of Joint Actions in European Cancer Care

Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e

0 views • 7 slides


National Cancer Patient Experience Survey 2021 Results Overview

National Cancer Patient Experience Survey (NCPES) for 2021 focused on brain tumour patients and was led by Lisa Wilks, the Lead Cancer Nurse at NBT. The survey, commissioned by NHS England, aimed to monitor cancer care progress, drive quality improvements, and inform stakeholders. Methodology includ

0 views • 26 slides